AC8.AU · AusCann Group Holdings Ltd

-

Please sign in to comment on AC8.AU

1 Comment

Admin

3 years, 7 months ago

AusCann Group Holdings Ltd is currently in a long term downtrend where the price is trading 27.9% below its 200 day moving average.

From a valuation standpoint, the stock is 6050.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 15832.4.

AusCann Group Holdings Ltd's total revenue sank by 64.2% to $92K since the same quarter in the previous year.

Its net income has dropped by 34.3% to $-5M since the same quarter in the previous year.

Finally, its free cash flow grew by 68.1% to $-2M since the same quarter in the previous year.

Based on the above factors, AusCann Group Holdings Ltd gets an overall score of 1/5.

ISIN	AU000000AC89
Sector	Healthcare
Industry	Drug Manufacturers-Specialty & Generic
CurrencyCode	AUD
Exchange	AU

Dividend Yield	0.0%
Target Price	None
Beta	0.94
Market Cap	18M
PE Ratio	0.0

ABOUT

AusCann Group Holdings Ltd

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

AC8.AU · AusCann Group Holdings Ltd

-

AusCann Group Holdings Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest AusCann Group Holdings Ltd using a moving average strategy